- Home
- DTSS vs NURO Comparison
DTSS vs NURO Comparison
Compare DTSS & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- NURO
- Stock Information
- Founded
- DTSS 2014
- NURO 1996
- Country
- DTSS China
- NURO United States
- Employees
- DTSS N/A
- NURO N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- NURO Medical/Dental Instruments
- Sector
- DTSS Technology
- NURO Health Care
- Exchange
- DTSS Nasdaq
- NURO Nasdaq
- Market Cap
- DTSS 10.3M
- NURO 8.2M
- IPO Year
- DTSS N/A
- NURO N/A
- Fundamental
- Price
- DTSS $2.38
- NURO $4.55
- Analyst Decision
- DTSS
- NURO
- Analyst Count
- DTSS 0
- NURO 0
- Target Price
- DTSS N/A
- NURO N/A
- AVG Volume (30 Days)
- DTSS 941.0K
- NURO 15.0K
- Earning Date
- DTSS 11-11-2024
- NURO 11-01-2024
- Dividend Yield
- DTSS N/A
- NURO N/A
- EPS Growth
- DTSS N/A
- NURO N/A
- EPS
- DTSS N/A
- NURO N/A
- Revenue
- DTSS $23,975,867.00
- NURO $4,383,614.00
- Revenue This Year
- DTSS N/A
- NURO N/A
- Revenue Next Year
- DTSS N/A
- NURO N/A
- P/E Ratio
- DTSS N/A
- NURO N/A
- Revenue Growth
- DTSS 558.55
- NURO N/A
- 52 Week Low
- DTSS $1.42
- NURO $2.66
- 52 Week High
- DTSS $20.29
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- DTSS 54.30
- NURO 65.06
- Support Level
- DTSS $2.10
- NURO $3.96
- Resistance Level
- DTSS $2.49
- NURO $4.69
- Average True Range (ATR)
- DTSS 0.23
- NURO 0.22
- MACD
- DTSS 0.00
- NURO 0.04
- Stochastic Oscillator
- DTSS 40.00
- NURO 82.35
About DTSS Datasea Inc.
Datasea Inc is a development stage company engaged in Internet security products. Its offers service and products such as Internet Security Equipment, New Media Advertising Service, Micro Marketing Service, Internet Service Provider (ISP) Connecting Service, Big Data Processing Service. The business activity of the group functions through China.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.